Evidence map›Paper›PMID 42282721›Full record

ArticlebioRxiv : the preprint server for biology2026

Atomic layer deposition for core-shell microparticle vaccines enabling programmable antigen delivery to lymph nodes enhance humoral immune responses.

Namit Chaudhary, Holly J Coleman, Elias V Paolone, Jiancheng Yu, Amir W Ledbetter, Ashley A Lemnios, Agnes A Walsh, Heikyung Suh, Alexander Wang, Maryam M Mansoor and 11 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Namit ChaudharyDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037.
Holly J ColemanDepartment of Chemical and Biological Engineering, University of Colorado, Boulder, CO 80309.
Elias V PaoloneDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037.
Jiancheng YuDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037.
Amir W LedbetterKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
Ashley A LemniosDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037.
Agnes A WalshDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037.
Heikyung SuhDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037.
Alexander WangDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037.
Maryam M MansoorDepartment of Bioengineering, University of California San Diego, La Jolla, CA 92093.
JoLynn B GiancolaDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037.
Mariane B MeloDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037.
Amber M RauchDepartment of Chemical and Biological Engineering, University of Colorado, Boulder, CO 80309.
Erika S LangsfeldThe BioFrontiers Institute, University of Colorado, Boulder, CO 80309.
Urvi R ParlikarDepartment of Chemical and Biological Engineering, University of Colorado, Boulder, CO 80309.
Marisa O PachecoDepartment of Chemical and Biological Engineering, University of Colorado, Boulder, CO 80309.
Carly A WilliamsDepartment of Chemical and Biological Engineering, University of Colorado, Boulder, CO 80309.
Hans H FunkeDepartment of Chemical and Biological Engineering, University of Colorado, Boulder, CO 80309.
Robert L GarceaThe BioFrontiers Institute, University of Colorado, Boulder, CO 80309.
Theodore W RandolphDepartment of Chemical and Biological Engineering, University of Colorado, Boulder, CO 80309.
Darrell J IrvineDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037.

Funding

Identification of neutralizing epitopes on SARS-CoV-2 spike for design of vaccines and small-molecule antiviralsUM1AI144462 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI BURTON, DENNIS R. · 2019 to 2025
$201.6M
Design of single-shot sequential immunization regimens for HIV using atomic layer deposition technology.R01AI192197 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI FLYNN, CLAUDIA, IRVINE, DARRELL J · 2025 to 2025
$3.0M
Interdisciplinary Predoctoral Training in Molecular BiophysicsT32GM145437 · NIGMS · UNIVERSITY OF COLORADO · PI JOSEPH J FALKE · 2022 to 2026
$2.5M
NIAID NIH HHS R01 AI192197NIAID NIH HHS UM1 AI144462NIGMS NIH HHS T32 GM145437
6 · The paper itself

Abstract

Technologies that simplify complex dosing regimens as single-shot immunizations may be important for vaccines against difficult to neutralize pathogens. Here we characterized delivery mechanism of clinically-relevant HIV vaccine immunogens using core-shell microparticles comprising immunogen formulations spray-dried to form solid spherical microparticles and subsequently coated with a nanoscopic alumina shell using atomic layer deposition (ALD). ALD particles exhibited a time delay in antigen release programmed by the alumina shell followed by prolonged antigen release, which steadily accumulated in antigen-presenting cells at the injection site and draining lymph nodes and accumulated on follicular dendritic cells in B cell follicles. ALD vaccines elicited continuous expansion of antigen-specific germinal center B cells over 8 weeks, serum antibody responses with >10-fold slower antigen-binding off-rates, and 2-fold more long-lived plasma cells compared to traditional bolus vaccination with potent adjuvants. Single administration ALD technology thus promotes key events in the primary immune response important for vaccines against HIV and other challenging pathogens.

Identifiers

PMID42282721
PMCPMC13252159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.